首页>
外国专利>
Pharmaceutical composition comprising a combination of Chondroitin sulfate and diacerein and their use in the treatment of osteoarthritis and related diseases
Pharmaceutical composition comprising a combination of Chondroitin sulfate and diacerein and their use in the treatment of osteoarthritis and related diseases
展开▼
机译：包含硫酸软骨素和双醋瑞因的组合的药物组合物及其在治疗骨关节炎和相关疾病中的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention refers to a drug synthesis composed of a synergistic combination of an anti arthritis agent (collectively referred to as a sulfuric acid condom) and an interleucine-1 inhibitor (collectively referred to as: diacereina, an acceptable pre drug disinfectant), which are prepared in one unit. The dosage taken with oral medicine is used to control and treat osteoarthritis and related diseases, which provides greater therapeutic effect, faster pharmacological reaction time and less pain,Changes in inflammation and structural diseases, as well as reduced risk of serious complications and / or side effects. 1. - the characteristic of the drug composition is that it is composed of the synergistic combination of anti arthritis agents, which is the active principle: sulfuric acid condom and an anti schistosome Agent-1, which is the active principle: diacereina, plus the acceptable pre drug disinfectant;In this case, the principle of activity exists in a concentration range from 100.0 mg. Sulfuric acid condom, up to 1.2g, up to 25.0mg. Up to 100.0 mg For deoxyribonucleic acids, they are developed in a single dose unit, administered orally, to control and treat osteoporosis and related diseases.
展开▼
